Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Inv. presentation
Quarterly results

Dimension Therapeutics, Inc. (DMTX) Create: Alert

All | News | Filings
Date FiledTypeDescription
11/09/2017 4 FMR LLC (See Remark 1) has filed a Form 4 on Dimension Therapeutics, Inc.
Txns: Unknown transaction of 3,838,249 shares @ $6, valued at $23M
Unknown transaction of 1,050,016 shares @ $6, valued at $6.3M
Unknown transaction of 5,057 shares @ $6, valued at $30.3k
11/07/2017 4 Wadsworth Samuel C. (Chief Scientific Officer) has filed a Form 4 on Dimension Therapeutics, Inc.
Txns: Disposed/sold 278,035 shares @ $0
Disposed/sold 50,000 options to buy @ $7.14, valued at $357k
Disposed/sold 60,000 options to buy @ $1.9, valued at $114k
11/07/2017 4 Thistle Mary (COO) has filed a Form 4 on Dimension Therapeutics, Inc.
Txns: Disposed/sold 27,711 options to buy @ $3.57, valued at $98.9k
Disposed/sold 180,815 options to buy @ $3.57, valued at $645.5k
Disposed/sold 17,104 options to buy @ $4.09, valued at $70k
Disposed/sold 65,000 options to buy @ $7.14, valued at $464.1k
Disposed/sold 60,000 options to buy @ $1.9, valued at $114k
11/07/2017 4 Morris Arlene (Director) has filed a Form 4 on Dimension Therapeutics, Inc.
Txns: Disposed/sold 44,474 options to buy @ $4.85, valued at $215.7k
Disposed/sold 32,069 options to buy @ $7.08, valued at $227k
Disposed/sold 17,000 options to buy @ $1.15, valued at $19.6k
11/07/2017 4 MIGAUSKY GEORGE V (Director) has filed a Form 4 on Dimension Therapeutics, Inc.
Txns: Disposed/sold 55,772 options to buy @ $4.09, valued at $228.1k
Disposed/sold 32,069 options to buy @ $7.08, valued at $227k
Disposed/sold 17,000 options to buy @ $1.15, valued at $19.6k
11/07/2017 4 Jenkins Annalisa (President and CEO) has filed a Form 4 on Dimension Therapeutics, Inc.
Txns: Disposed/sold 481,696 options to buy @ $0.56, valued at $269.7k
Disposed/sold 74,375 options to buy @ $3.57, valued at $265.5k
Disposed/sold 342,113 options to buy @ $4.09, valued at $1.4M
Disposed/sold 160,000 options to buy @ $7.14, valued at $1.1M
Disposed/sold 192,000 options to buy @ $1.9, valued at $364.8k
Disposed/sold 150,000 options to buy @ $1.35, valued at $202.5k
11/07/2017 4 Hohneker John (Director) has filed a Form 4 on Dimension Therapeutics, Inc.
Txns: Disposed/sold 38,000 options to buy @ $4.6, valued at $174.8k
11/07/2017 4 GEMAYEL GEORGES (Director) has filed a Form 4 on Dimension Therapeutics, Inc.
Txns: Disposed/sold 44,474 options to buy @ $4.85, valued at $215.7k
Disposed/sold 32,069 options to buy @ $7.08, valued at $227k
Disposed/sold 17,000 options to buy @ $1.15, valued at $19.6k
11/07/2017 4 Dybbs Michael (Director) has filed a Form 4 on Dimension Therapeutics, Inc.
Txns: Disposed/sold 32,069 options to buy @ $7.08, valued at $227k
Disposed/sold 17,000 options to buy @ $1.15, valued at $19.6k
11/07/2017 4 Crombez Eric (Chief Medical Officer) has filed a Form 4 on Dimension Therapeutics, Inc.
Txns: Disposed/sold 128,292 options to buy @ $0.56, valued at $71.8k
Disposed/sold 80,396 options to buy @ $4.09, valued at $328.8k
Disposed/sold 50,000 options to buy @ $7.14, valued at $357k
Disposed/sold 50,000 options to buy @ $1.9, valued at $95k
11/07/2017 4 Colowick Alan (Director) has filed a Form 4 on Dimension Therapeutics, Inc.
Txns: Disposed/sold 44,474 options to buy @ $4.85, valued at $215.7k
Disposed/sold 17,000 options to buy @ $1.15, valued at $19.6k
Disposed/sold 32,069 options to buy @ $7.08, valued at $227k
07/05/2017 4 Jenkins Annalisa (President and CEO) has filed a Form 4 on Dimension Therapeutics, Inc.
Txns: Granted 150,000 options to buy @ $1.35, valued at $202.5k
05/26/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
05/26/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
05/26/2017 4 Dybbs Michael (Director) has filed a Form 4 on Dimension Therapeutics, Inc.
Txns: Granted 17,000 options to buy @ $1.15, valued at $19.6k
05/26/2017 4 Colowick Alan (Director) has filed a Form 4 on Dimension Therapeutics, Inc.
Txns: Granted 17,000 options to buy @ $1.15, valued at $19.6k
05/26/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
02/03/2017 4 Jenkins Annalisa (President and CEO) has filed a Form 4 on Dimension Therapeutics, Inc.
Txns: Granted 192,000 options to buy @ $1.9, valued at $364.8k
02/03/2017 4 Wadsworth Samuel C. (Chief Scientific Officer) has filed a Form 4 on Dimension Therapeutics, Inc.
Txns: Granted 60,000 options to buy @ $1.9, valued at $114k
02/03/2017 4 Clark K. Reed (SVP of Pharmaceutical Develop) has filed a Form 4 on Dimension Therapeutics, Inc.
Txns: Granted 40,000 options to buy @ $1.9, valued at $76k
02/03/2017 4 Crombez Eric (Chief Medical Officer) has filed a Form 4 on Dimension Therapeutics, Inc.
Txns: Granted 50,000 options to buy @ $1.9, valued at $95k
02/03/2017 4 Franchi Jean M. (CFO) has filed a Form 4 on Dimension Therapeutics, Inc.
Txns: Granted 60,000 options to buy @ $1.9, valued at $114k
02/03/2017 4 Thistle Mary (COO) has filed a Form 4 on Dimension Therapeutics, Inc.
Txns: Granted 60,000 options to buy @ $1.9, valued at $114k
01/20/2017 4 Hohneker John (Director) has filed a Form 4 on Dimension Therapeutics, Inc.
06/08/2016 4 Clark K. Reed (SVP of Pharmaceutical Develop) has filed a Form 4 on Dimension Therapeutics, Inc.
Txns: Sold 5,000 shares @ $10, valued at $50k
Exercised 5,000 options to buy @ $0.38, valued at $1.9k
05/23/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
05/23/2016 4 MIGAUSKY GEORGE V (Director) has filed a Form 4 on Dimension Therapeutics, Inc.
Txns: Granted 32,069 options to buy @ $7.08, valued at $227k
05/23/2016 4 Gupta Rishi (Director) has filed a Form 4 on Dimension Therapeutics, Inc.
Txns: Granted 32,069 options to buy @ $7.08, valued at $227k
05/23/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
05/23/2016 4 Dybbs Michael (Director) has filed a Form 4 on Dimension Therapeutics, Inc.
05/23/2016 4 Colowick Alan (Director) has filed a Form 4 on Dimension Therapeutics, Inc.
Txns: Granted 32,069 options to buy @ $7.08, valued at $227k
05/03/2016 4 Form 4 - Statement of changes in beneficial ownership of securities

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy